The budget reconciliation process and President Donald Trump’s (R) priorities are expected to continue dominating Washington D.C. politics in the [...] …
Year: 2025
SPONSORED CONTENT
The 340B Drug Pricing Program is at a crossroads, facing increased scrutiny, manufacturer restrictions, and ongoing legal battles. In this must-watch webinar, industry experts Ted Slafsky (340B Report), Emily Cook (McDermott, Will & Emery), and Nicole Shoquist (JPS Health Network) break down the
…
After almost cancelling the vote in a last minute search for support, U.S. House Majority Leader Mike Johnson (R-La.) muscled [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The University of Kansas Hospital (UKHA) this week sued the federal government for authorizing Johnson & Johnson (J&J) to audit [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
TIP: Master manufacturer refund challenges with actionable steps.
Managing manufacturer refunds in the 340B Drug Pricing Program
News Alert
Dark-Money 340B Attacks, Rebate Model Among Key Concerns at 340B Coalition Winter Conference
Concerns over a highly charged and misleading dark-money campaign targeting state contract pharmacy access bills and the legal fight surrounding [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge yesterday rejected Swiss pharmaceutical company Novartis’ bid to block Missouri’s law prohibiting drugmaker 340B contract pharmacy restrictions [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
California lawmakers have introduced a 340B contract pharmacy access bill; Michigan legislators introduced a contract pharmacy bill that also includes [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
U.S. House lawmakers are expected to vote as early as Tuesday on a budget resolution that calls for reducing health [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
The healthcare landscape is evolving rapidly, and with it, the need for stronger, smarter partnerships has never been greater. Covered entities are navigating a time of uncertainty, where operational challenges, regulatory scrutiny, and resource constraints are putting unprecedented pressure on healthcare organizations. That’s why
…